Therapeutic Approaches to Prion Diseases

Area of Science:

• Neuroscience
• Drug Discovery
• Prion Biology

Background:

• Prion diseases pose significant therapeutic challenges, evidenced by decades of clinical trial failures.
• The understanding of prion-like spreading mechanisms in other neurodegenerative diseases is now influencing prion disease drug discovery.
• Previous efforts focused on repositioned drugs, but none proved successful.

Purpose of the Study:

• To review historical and current efforts in prion disease drug discovery.
• To highlight novel therapeutic strategies, including multitarget compounds and theranostics.
• To underscore the potential of innovative approaches in addressing prion disease pathogenesis.

Main Methods:

• Analysis of historical clinical trial data for repositioned drugs in prion diseases.
• Exploration of emerging therapeutic strategies targeting multifactorial prion disease pathogenesis.
• Investigation into the development of theranostic agents for combined diagnosis and therapy.

Main Results:

• Chemically diverse repositioned drugs have failed to demonstrate efficacy in clinical trials for prion diseases.
• Novel approaches are being pursued, focusing on small molecules targeting multiple pathological pathways (multitarget compounds).
• Theranostics, combining therapeutic and diagnostic capabilities, are emerging as a promising avenue.

Conclusions:

• Despite past setbacks, the field of prion disease therapy is advancing with innovative strategies.
• Multitarget compounds and theranostics offer new hope for addressing the complex nature of prion diseases.
• While clinical translation is demanding, these novel approaches hold significant promise for future therapeutic development.